The global cancer genome sequencing market is segmented on the basis of technology and geography. The currently technologies used include second generation and third generation platforms. Second generation technology platforms include SOLiD sequencing (by ABI), Pyro-sequencing (by Roche) and Bridge amplification sequencing technology (by Illumina). Third generation technology platform includes Single Molecule Real Time (SMRT) sequencing (by Pacific Biosciences), Ion semiconductor sequencing, Nanopore sequencing (by Oxford) and fluorescent resonant energy transfer (FRET) sequencing (by VisiGen biotechnologies). Geographically, the global cancer genome sequencing market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America dominates the global cancer genome sequencing market due to availability of advanced technologies and a skilled workforce. This market is driven by whole genome sequencing coupled with bioinformatics based sequencing technologies which provide personalized treatments for cancer.
KEY BENEFITS
This report offers the following benefits in particular:
Pin-point analysis of geographic segments helps to identify opportunities for growth within the global cancer genome sequencing market
Porter’s Five Forces analysis examines the competitive structure of the global cancer genome sequencing market and would assist market strategists in their decision-making process.
In-depth coverage of the global cancer genome sequencing market including drivers, restraints and opportunities would help professionals to better understand market behavior
Detailed study of the strategies of key leaders, partnerships and acquisitions in the global cancer genome sequencing market would be informative for professionals in the corporate sector
KEY MARKET SEGMENTS
The global cancer genome sequencing market is segmented into two broad categories: technology and geography.
MARKET BY TECHNOLOGY
Second Generation Technology Platforms
SOLiD sequencing (by ABI)
Pyro-sequencing (by Roche)
Bridge amplification sequencing technology (by Illumina)
Third Generation Technology Platforms
Single Molecule Real Time (SMRT) sequencing (by Pacific Biosciences)
Ion semiconductor sequencing.
Nanopore sequencing (by Oxford)
fluorescent resonant energy transfer (FRET) sequencing (by VisiGen biotechnologies)
MARKET BY GEOGRAPHY
North America
Europe
Asia-Pacific
LAMEA
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...